News

In 2021, ATYR completed a phase 1b/2a trial in pulmonary sarcoidosis, and have since started a phase 3 trial. Currently the ...
Representatives with the United Coal Workers of America have condemned a federal court’s decision to continue delaying the ...
Secondhand Smoke: Even non-smokers can be affected by the smoke inhaled from others, particularly in enclosed spaces. Studies show that individuals regularly exposed to secondhand smoke have a higher ...
The A5 nanobody is around 10 times smaller than conventional antibodies, helping it to penetrate deep into tissues. Crucially, it can bind selectively to cancer cells, leading to a reduction of more ...
In a significant research advancement that may help inform treatment strategies for millions of patients worldwide, a ...
The FDA granted breakthrough therapy designation to Ifinatamab deruxtecan for some with extensive-stage small cell lung ...
A group of nerve cells known for their role in detecting chemical irritation, tissue damage, heat, and pressure now emerge as ...
For the first time in three decades, the American Academy of Pediatrics is substantially diverging from U.S. government ...
Every breath sustains life, though few recognize how routine decisions shape respiratory wellness. Innovative interventions, ...
When you contract the flu or COVID, your body releases inflammatory cytokines that help fight the pathogen and heal damaged ...
By Lauren St. Germain Click here for updates on this story TAMPA, Florida (WFTS) -- There are some truly inspiring people who ...
An executive cites the company's 140-year track record as it faces federal action on drug pricing and industry tariffs.